Technical Analysis for HZNP - Horizon Pharma, Inc.

Grade Last Price % Change Price Change
C 89.3 -1.58% -1.43
HZNP closed down 1.58 percent on Wednesday, May 5, 2021, on 1.64 times normal volume. The stock fell below its 50 day moving average, damaging its intermediate-term outlook by crossing under that important trendline.

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Up Down Down
Historical HZNP trend table...

Date Alert Name Type % Chg
Fell Below 50 DMA Bearish 0.00%
Bollinger Band Squeeze Range Contraction 0.00%
Doji - Bullish? Reversal 0.00%
Earnings Movers Other 0.00%
Multiple of Ten Bearish Other 0.00%
BB Squeeze + Lower Band Touch Range Contraction 0.00%
Outside Day Range Expansion 0.00%
Down 3 Days in a Row Weakness 0.00%
Down 4 Days in a Row Weakness 0.00%
Down 5 Days in a Row Weakness 0.00%
Older End-of-Day Signals for HZNP ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
60 Minute Opening Range Breakdown about 12 hours ago
Down 1 ATR about 12 hours ago
Lower Bollinger Band Support about 13 hours ago
1.5x Volume Pace about 14 hours ago
Down 3% about 14 hours ago
View Earlier Intraday Alerts

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.


Horizon Pharma, Inc. Description

Horizon Pharma, Inc., a specialty pharmaceutical company, through its subsidiaries, develops and commercializes medicines for the treatment of arthritis, pain, and inflammatory diseases. The company offers DUEXIS, a proprietary tablet formulation for the relief of signs and symptoms of rheumatoid arthritis and osteoarthritis, and to decrease the risk of developing upper gastrointestinal ulcers in patients who are taking ibuprofen for these indications. It also provides LODOTRA/RAYOS, a proprietary delayed-release formulation of low-dose prednisone for the treatment of moderate to severe active rheumatoid arthritis in adults when accompanied by morning stiffness, as well as approved for the treatment of polymyalgia rheumatica, psoriatic arthritis, ankylosing spondylitis, asthma, chronic obstructive pulmonary disease, and other conditions. The company was founded in 2005 and is headquartered in Deerfield, Illinois.


Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Keywords: Medicine Pharmaceutical Pain Autoimmune Diseases Gastrointestinal Inflammatory Disease Symptoms Inflammatory Diseases Rheumatoid Arthritis Asthma Osteoarthritis Pulmonary Disease Ulcer Chronic Obstructive Pulmonary Disease Deerfield Arthritis Rheumatology Ibuprofen

Is HZNP a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength


Indicator Value
52 Week High 97.17
52 Week Low 41.525
Average Volume 1,700,625
200-Day Moving Average 78.90
50-Day Moving Average 90.47
20-Day Moving Average 92.69
10-Day Moving Average 93.68
Average True Range 3.43
ADX 15.93
+DI 19.14
-DI 23.77
Chandelier Exit (Long, 3 ATRs ) 86.87
Chandelier Exit (Short, 3 ATRs ) 97.32
Upper Bollinger Band 96.56
Lower Bollinger Band 88.82
Percent B (%b) 0.06
BandWidth 8.35
MACD Line 0.79
MACD Signal Line 1.35
MACD Histogram -0.5623
Fundamentals Value
Market Cap 19.71 Billion
Num Shares 221 Million
EPS 3.61
Price-to-Earnings (P/E) Ratio 24.72
Price-to-Sales 8.49
Price-to-Book 3.98
PEG Ratio 1.00
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 96.68
Resistance 3 (R3) 96.74 94.34 95.45
Resistance 2 (R2) 94.34 92.46 94.31 95.04
Resistance 1 (R1) 91.82 91.30 93.08 91.76 94.63
Pivot Point 89.42 89.42 90.05 89.39 89.42
Support 1 (S1) 86.90 87.54 88.16 86.84 83.97
Support 2 (S2) 84.50 86.38 84.47 83.56
Support 3 (S3) 81.98 84.50 83.15
Support 4 (S4) 81.92